Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emily Smith

Showing results (251-260 of 287) with videos related to

Pageof 29
Sort By:
Journal for Immunotherapy of Cancer|May 30, 2019
Generation of monocyte-derived tumor-associated macrophages using tumor-conditioned media provides a novel method to study tumor-associated macrophages in vitroBrooke Benner, Luke Scarberry, Lorena P Suarez-Kelly, et al.
Optics Express|April 11, 2014
Spectrally-resolved fluorescence cross sections of aerosolized biological live agents and simulants using five excitation wavelengths in a BSL-3 laboratoryYong-Le Pan, Steven C Hill, Joshua L Santarpia, et al.
Psychological Medicine|June 12, 2018
Aggressive behaviour in childhood and adolescence: the role of smoking during pregnancy, evidence from four twin cohorts in the EU-ACTION consortiumMargherita Malanchini, Emily Smith-Woolley, Ziada Ayorech, et al.
Trials|February 25, 2012
Efficacy of early neonatal vitamin A supplementation in reducing mortality during infancy in Ghana, India and Tanzania: study protocol for a randomized controlled trial, Rajiv Bahl, Nita Bhandari, et al.
Journal of Genetic Counseling|May 5, 2017
Erratum to: At the Heart of the Pregnancy: What Prenatal and Cardiovascular Genetic Counselors Need to Know about Maternal Heart DiseaseAna Morales, Dawn C Allain, Patricia Arscott, et al.
Journal of Genetic Counseling|March 12, 2017
At the Heart of the Pregnancy: What Prenatal and Cardiovascular Genetic Counselors Need to Know about Maternal Heart DiseaseAna Morales, Dawn C Allain, Patricia Arscott, et al.
Clinical Pharmacology and Therapeutics|June 28, 2025
Impact of First-of-Its-Kind Patient-Facing Pharmacogenetics Tool on Dosing Decisions and Treatment OutcomesYoungwoo Cho, Sami Elahi, Matthew M Jack, et al.
Oncotarget|September 25, 2023
Correction: HDAC inhibitor AR-42 decreases CD44 expression and sensitizes myeloma cells to lenalidomideAlessandro Canella, Hector Cordero Nieves, Douglas W Sborov, et al.
Thorax|May 30, 2025
Effect of elexacaftor/tezacaftor/ivacaftor on systemic inflammation in cystic fibrosisRosemary E Maher, Urszula M Cytlak-Chaudhuri, Saad Aleem, et al.
Oncotarget|October 3, 2015
HDAC inhibitor AR-42 decreases CD44 expression and sensitizes myeloma cells to lenalidomideAlessandro Canella, Hector Cordero Nieves, Douglas W Sborov, et al.
Pageof 29

Showing results (251-260 of 287) with videos related to

Sort By:
Pageof 29
Journal for Immunotherapy of Cancer|May 30, 2019
Generation of monocyte-derived tumor-associated macrophages using tumor-conditioned media provides a novel method to study tumor-associated macrophages in vitroBrooke Benner, Luke Scarberry, Lorena P Suarez-Kelly, et al.
Optics Express|April 11, 2014
Spectrally-resolved fluorescence cross sections of aerosolized biological live agents and simulants using five excitation wavelengths in a BSL-3 laboratoryYong-Le Pan, Steven C Hill, Joshua L Santarpia, et al.
Psychological Medicine|June 12, 2018
Aggressive behaviour in childhood and adolescence: the role of smoking during pregnancy, evidence from four twin cohorts in the EU-ACTION consortiumMargherita Malanchini, Emily Smith-Woolley, Ziada Ayorech, et al.
Trials|February 25, 2012
Efficacy of early neonatal vitamin A supplementation in reducing mortality during infancy in Ghana, India and Tanzania: study protocol for a randomized controlled trial, Rajiv Bahl, Nita Bhandari, et al.
Journal of Genetic Counseling|May 5, 2017
Erratum to: At the Heart of the Pregnancy: What Prenatal and Cardiovascular Genetic Counselors Need to Know about Maternal Heart DiseaseAna Morales, Dawn C Allain, Patricia Arscott, et al.
Journal of Genetic Counseling|March 12, 2017
At the Heart of the Pregnancy: What Prenatal and Cardiovascular Genetic Counselors Need to Know about Maternal Heart DiseaseAna Morales, Dawn C Allain, Patricia Arscott, et al.
Clinical Pharmacology and Therapeutics|June 28, 2025
Impact of First-of-Its-Kind Patient-Facing Pharmacogenetics Tool on Dosing Decisions and Treatment OutcomesYoungwoo Cho, Sami Elahi, Matthew M Jack, et al.
Oncotarget|September 25, 2023
Correction: HDAC inhibitor AR-42 decreases CD44 expression and sensitizes myeloma cells to lenalidomideAlessandro Canella, Hector Cordero Nieves, Douglas W Sborov, et al.
Thorax|May 30, 2025
Effect of elexacaftor/tezacaftor/ivacaftor on systemic inflammation in cystic fibrosisRosemary E Maher, Urszula M Cytlak-Chaudhuri, Saad Aleem, et al.
Oncotarget|October 3, 2015
HDAC inhibitor AR-42 decreases CD44 expression and sensitizes myeloma cells to lenalidomideAlessandro Canella, Hector Cordero Nieves, Douglas W Sborov, et al.
Pageof 29